| 12 Décembre 2016
The  program aims to increase the availability of essential medicines and  improve care for patients across the region by using simple, available,  and affordable technology
BASEL, Switzerland, December 12, 2016/
Novartis (www.Novartis.com)  announced today the launch of an innovative technology-based healthcare  program called SMS for Life 2.0 in Kaduna State, Nigeria. The program  aims to increase the availability of essential medicines and improve  care for patients across the region by using simple, available, and  affordable technology. SMS for Life 2.0 is a joint public-private  partnership led by Novartis and supported by its partners, the Kaduna  State Ministry of Health and Vodacom.
“Novartis is proud to  partner with the Kaduna State Ministry of Health to implement the first  ever SMS for Life 2.0 program,” said Joseph Jimenez, CEO of Novartis.  “Companies must join forces with the public sector to co-create  innovative solutions to improve access to healthcare around the world.  This is the first step in what we hope will be an impactful public  health initiative, unleashing the potential of mobile technology and big  data to increase the quality of care for underserved patients.”
SMS  for Life 2.0 builds on the SMS for Life program launched by Novartis in  2009, which used cell phones to manage stock-outs of malaria medicines  in more than 10,000 healthcare facilities in sub-Saharan countries. The  new and enhanced SMS for Life 2.0 program will now use smartphones and  tablet computers to address key operational challenges at peripheral  healthcare facilities in Kaduna State. Local healthcare workers will be  able to track stock levels of essential antimalarials, vaccines, and  HIV, TB and leprosy treatments, and send notifications to district  medical officers when stock levels are low. The program will also  monitor surveillance parameters of malaria, maternal and infant deaths  and seven other diseases, including measles, yellow fever and cholera.  In addition, SMS for Life 2.0 will enable training of healthcare workers  in local facilities using on-demand eLearning modules.
“We  welcome the introduction of SMS for Life 2.0 in primary healthcare  facilities, where we often face stockouts of medicines,” said Dr. Hadiza  S. Balarabe, Executive Secretary of Kaduna State Primary Health Care  Development Agency. “With more than six million people, Kaduna is  Nigeria’s third most populous state. We hope the program will improve  healthcare services by expanding access to essential medicines, thus  reducing disease prevalence in communities.”
Medicines do not  always reach the patients who need them, particularly those living in  remote areas. Running out of stock is a major hurdle in ensuring access  to essential treatments. By increasing stock visibility, health  authorities will be able to monitor stock levels of these medicines in  real time. Furthermore, disease surveillance data combined with the  stock reporting function can improve supply chain management, by  allowing authorities to better forecast demand for the treatments. This  will help to ensure people get the medicines they need in a timely  fashion.
“Vodacom believes that mobile technology is a powerful  platform to address healthcare problems in Africa,” said Vuyani Jarana,  Chief Officer of Vodacom Business. “Our vision in partnering with Kaduna  State is to support the development of productive societies which are  healthy, well-educated and economically active. The SMS for Life 2.0  initiative will contribute towards better quality and more accessible  healthcare services which will in turn contribute to an increase in life  expectancy in Nigeria.”
In addition to the launch in Nigeria,  Novartis and its non-profit partner Right to Care, have signed a  memorandum of understanding with the Zambian Ministry of Health to  deploy SMS for Life 2.0 in up to 2,000 health facilities across the  country. The program, which will include stock reporting, disease  surveillance and eLearning, will be supported by Vodacom and is expected  to launch in Q2 2017.